These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
734 related articles for article (PubMed ID: 17020782)
1. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A; Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782 [TBL] [Abstract][Full Text] [Related]
2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; ViganĂ² D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome. Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
5. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing. Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672 [TBL] [Abstract][Full Text] [Related]
7. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome. Hanly JG; Smith SA J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Persijn L; Decavele AS; Schouwers S; Devreese K Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896 [TBL] [Abstract][Full Text] [Related]
9. European attempts for the standardisation of the antiphospholipid antibodies. Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of new commercial enzyme-linked immunosorbent assay kits in the laboratory diagnosis of antiphospholipid syndrome in view of the revised classification criteria of the antiphospholipid syndrome. Devreese KM Blood Coagul Fibrinolysis; 2006 Nov; 17(8):651-9. PubMed ID: 17102652 [TBL] [Abstract][Full Text] [Related]
11. Antiprothrombin antibody: why do we need more assays? Atsumi T; Koike T Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984 [TBL] [Abstract][Full Text] [Related]
12. Laboratory evaluation of the antiphospholipid syndrome. Abo SM; DeBari VA Ann Clin Lab Sci; 2007; 37(1):3-14. PubMed ID: 17311864 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Decavele AS; Schouwers S; Devreese KM Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022 [TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
16. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis. Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883 [TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A; Kickler TS; Petri M J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938 [TBL] [Abstract][Full Text] [Related]
18. Real world experience with antiphospholipid antibody tests: how stable are results over time? Erkan D; Derksen WJ; Kaplan V; Sammaritano L; Pierangeli SS; Roubey R; Lockshin MD Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290 [TBL] [Abstract][Full Text] [Related]
19. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome. Suh-Lailam BB; Cromar A; Davis KW; Tebo AE Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475 [TBL] [Abstract][Full Text] [Related]
20. Clinical laboratory testing for the antiphospholipid syndrome. Pierangeli SS; Harris EN Clin Chim Acta; 2005 Jul; 357(1):17-33. PubMed ID: 15893301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]